Log in to search using one of your social media accounts:

 

TIME 100 ’s Giuliano Testa: We Should Think About Infertility As a ‘Wellbeing Issue’

Dr. Giuliano Testa, a transplant surgeon at Baylor University Medical Center at Dallas who led the medical team that performed the first successful uterus transplants in the United States, said Tuesday that he hopes “what we are doing is going to shed light on infertility for women.” “I personally never knew it was such a widespread issue,” Testa said at the TIME 100 Gala on Tuesday. “We should be thinking about it not just as a birth, but a wellbeing issue.” Testa attended the TIME 100 Gala after being named by TIME magazine as one of the most influential people in the world for his role in helping women give birth via uterus transplant. MORE: The 100 Most Influential People of 2018 Women who participate in Testa’s trial have absolute uterine factor infertility (AUI), which means their uterus is nonfunctioning or nonexistent. Most of the women have a condition called Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, which means they were born without a uterus and lived their entire lives under the assumption that they would never be able to be pregnant or give birth to a baby. The procedure can also work for women with other medical issues, such as certain cancers. MORE: First U.S. Baby Born After a Uterus Transplant In a tribute to Testa for the 2018 TIME 100, the first woman who gave birth to a baby via uterus transplant (and who wishes to remain anonymous) recalled giving birth to a healthy baby boy in November. “As I h...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized onetime T1002018 Source Type: news

Related Links:

STOMACH cancer symptoms include a poor appetite, weight loss, and nausea. Treatment can include operations as well as changes to what you eat. Adapting your diet to include more of these foods could help to treat the condition.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
At 12 weeks pregnant, doting mother Yana Williams, from NSW, was given the heartbreaking news that one of her twins was not going to survive. Here, she shares her heartbreaking story.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This report warns that reluctance to talk honestly about death is preventing people with cancer from dying'well'. It calls for Governments across the UK to honour their commitments to ensuring Advance Care Planning is used as an important part of a person-centred health service, so that people approaching the end of their lives receive the best care possible and their wishes for death and dying are fulfilled
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
AN artificial intelligence revolution to prevent 22,000 cancer deaths by 2033 was being unveiled today. Theresa May is challenging the NHS to transform healthcare.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
At 12 weeks pregnant, doting mother Yana Williams, from NSW, was given the heartbreaking news that one of her twins was not going to survive. Here, she shares her heartbreaking story.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after>10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA). Int J Cardiol. 2018 Aug 01;264:158-164 Authors: Cainzos-Achirica M, Miedema MD, McEvoy JW, Cushman M, Dardari Z, Greenland P, Nasir K, Budoff MJ, Al-Mallah MH, Yeboah J, Blumenthal RS, Comin-Colet J, Blaha MJ Abstract BACKGROUND: The prognostic value of hsCRP in contemporary multi-ethnic populations is unclear, particularly in statin users. The aim of this study was to characterize the prognostic utility of hsCRP for atheroscleroti...
Source: Atherosclerosis - Category: Cardiology Authors: Tags: Int J Cardiol Source Type: research
Abstract The molecular pathogenesis and classification of colorectal carcinoma are based on the traditional adenomaecarcinoma sequence, serrated polyp pathway, and microsatellite instability (MSI). The genetic basis for hereditary nonpolyposis colorectal cancer is the detection of mutations in the MLH1, MSH2, MSH6, PMS2, and EPCAM genes. Genetic testing for Lynch syndrome includes MSI testing, methylator phenotype testing, BRAF mutation testing, and molecular testing for germline mutations in MMR genes. Molecular makers with predictive and prognostic implications include quantitative multigene reverse transcriptas...
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Tags: Clin Lab Med Source Type: research
Abstract MicroRNAs (miRNAs) are poised to provide diagnostic, prognostic, and therapeutic targets for several diseases including malignancies for precision medicine applications. The miRNAs have immense potential in the clinical arena because they can be detected in the blood, serum, tissues (fresh and formalin-fixed paraffin-embedded), and fine-needle aspirate specimens. The most attractive feature of miRNA-based therapy is that a single miRNA could be useful for targeting multiple genes that are deregulated in cancers, which can be further investigated through systems biology and network analysis that may provid...
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: Clin Lab Med Source Type: research
CONCLUSIONS: Ring-shaped thread counter traction makes the most difficult duodenal ESD safer and easier without complications. PMID: 29764299 [PubMed - as supplied by publisher]
Source: Minimally Invasive Therapy and Allied Technologies - Category: Surgery Tags: Minim Invasive Ther Allied Technol Source Type: research
Novel concepts employing autologous, ex  vivo expanded natural regulatory T cells (nTreg) for adoptive transfer has potential to prevent organ rejection after kidney transplantation. However, the impact of dialysis and maintenance immunosuppression on the nTreg phenotype and peripheral survival is not well understood, but essential when assessing patient eligibility. The current study investigates regulatory T-cells in dialysis and kidney transplanted patients and the feasibility of generating a clinically useful nTreg product from these patients.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Clinical Investigation Source Type: research
More News: Babies | Cancer | Cancer & Oncology | Cancer of the Uterus | Health | Infertility | MRKH Syndrome | Pregnancy | Reproduction Medicine | Transplant Surgery | Transplants | USA Health | Women